Lujan Grisham Offers Budget Amendment to Lower Prescription Drug Costs

Press Release

Congresswoman Michelle Lujan Grisham (NM-01) sponsored an amendment to the federal budget resolution to lower the costs of life-saving prescription drugs. She also spoke on the floor of the House today about reducing drug costs.

The Republican-sponsored budget sets the stage to repeal the Affordable Care Act and allow big pharmaceutical companies to escape any changes to a system that has repeatedly allowed them to prioritize profits over people and drive increases in out-of-pocket health care costs.

The amendment sponsored by Lujan Grisham, Doggett and Welch is designed to counter the effects of the Republican budget plan.

"Companies like Mylan, Turing, and Valeant are jacking up prices on life-saving drugs like Epi-pen, Daraprim, and Nitropress overnight without any accountability," Rep. Lujan Grisham said. "While the American people increasingly can't afford their medicine, pharmaceutical companies are the wealthiest they've been in years. Instead of fighting to make sure Americans have access to life-saving medications, Republicans are protecting the ability of pharmaceutical companies to continue to shake down the American people."

The House is considering the Senate Budget Resolution today.

Source